Rapivab - Antiviral for Influenza Treatment

Rapivab is an intravenous antiviral medication used for the treatment of acute uncomplicated influenza in patients 2 years and older who have been symptomatic for no more than 2 days.
Category
Drug
Where to get
Administered in healthcare facilities.
Applicable for
Prepared by Shruti Sahoo, reviewed by Dr. Eugene Smith

Rapivab FAQ


Image credit: medscape.com

What is Rapivab used for?

Rapivab is a brand-name prescription medication. It’s FDA-approved to treat influenza (the flu) in people ages 2 years and older. Rapivab should only be used in people with the flu who haven’t had symptoms for longer than 2 days. And, Rapivab shouldn’t be used to treat influenza that’s severe enough to require that you stay in the hospital.

How effective is Rapivab?

Efficacy of RAPIVAB is based on clinical trials of naturally occurring influenza in which the predominant influenza infections were influenza A virus; a limited number of subjects infected with influenza B virus were enrolled. Influenza viruses change over time. Emergence of resistance substitutions could decrease drug effectiveness.

What is Rapivab (peramivir)?

What Is Rapivab? Rapivab (peramivir) is an inhibitor of influenza virus neuraminidase used to treat acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than 2 days. What Are Side Effects of Rapivab?

Is Rapivab FDA approved?

Rapivab is FDA-approved to treat influenza (the flu) in people ages 2 years and older. Specifically, the drug is approved for use in people who’ve had flu symptoms for no more than 2 days. Influenza is an infection that’s caused by the influenza virus. There are three types of influenza viruses: type A, B, and C.

When is Rapivab indicated for the treatment of acute uncomplicated influenza?

RAPIVAB is indicated for the treatment of acute uncomplicated influenza in patients 6 months and older who have been symptomatic for no more than 2 days.

Rapivab References

If you want to know more about Rapivab, consider exploring links below:

Explore Related Topics

Harnessing Combination Therapy to Combat Antiviral Resistance in Influenza

Discuss the concept of combination therapy in combating antiviral resistance in influenza. Share insights on the rationale, efficacy, and challenges associated with using multiple antiviral agents concurrently to overcome resistance and enhance treatment outcomes.

Antiviral Resistance Surveillance in Influenza: Best Practices and Innovations

Explore the importance of antiviral resistance surveillance in monitoring influenza strains. Share best practices, technology-driven innovations, and global initiatives aimed at enhancing surveillance systems to detect, track, and respond to antiviral resistance outbreaks effectively.

How do antiviral medications for influenza differ from antibiotics?

Explore the distinctions between antiviral medications used to treat influenza and antibiotics, outlining their respective functions and applications.

Are antiviral medications effective in preventing the flu?

Share the effectiveness of antiviral medications in preventing the flu, including their role in reducing the severity and duration of symptoms.

Recommended Links